Hyperlipidaemia: A Review of Literature

Abstract

Since the beginning of time people have used plants as a solution for different infections and/or diseases. With the approach of current synthetic medicines, plant medication has frequently been subjected to the edge of therapeutic modalities. However, it is progressively being recognized that the synthetic therapeutic agents have a few limitations particularly in ongoing chronic illnesses like hyperlipidaemia. Hyperlipidaemia is an ailment characterised by an expansion in at least one of the plasma lipids, including cholesterol, triglycerides, plasma lipoproteins such as low density lipoprotein (LDL) and very low density lipoprotein (VLDL) alongside diminished high-density lipoprotein (HDL) levels. Research is continuous to find more current medications and a few novel helpful targets are being investigated for hyperlipidaemia. In the current review, the types of hyperlipidaemias, lipid metabolism, causes and risk factors of hyperlipidaemia has been explained along side the plant derived bioactiveand extracts that have been demonstrated in the past 15 years to have a potential in treatment of hyperlipidaemia has been discussed.